Given the increased secretion of pro-inflammatory IL-6 observed in MCs treated with LpX in the presence of amiodarone (Fig 7), amiodarone and other drugs that cause phospholipidosis could potentially exacerbate the renal disease associated with FLD. This evidence concerns the gene IL6 and lysosomal storage disease.